- Home
- CIA vs SGMO Comparison
CIA vs SGMO Comparison
Compare CIA & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIA
- SGMO
- Stock Information
- Founded
- CIA 1969
- SGMO 1995
- Country
- CIA United States
- SGMO United States
- Employees
- CIA N/A
- SGMO N/A
- Industry
- CIA Life Insurance
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIA Finance
- SGMO Health Care
- Exchange
- CIA Nasdaq
- SGMO Nasdaq
- Market Cap
- CIA 222.9M
- SGMO 180.5M
- IPO Year
- CIA N/A
- SGMO 2000
- Fundamental
- Price
- CIA $4.58
- SGMO $2.05
- Analyst Decision
- CIA
- SGMO Buy
- Analyst Count
- CIA 0
- SGMO 3
- Target Price
- CIA N/A
- SGMO $7.00
- AVG Volume (30 Days)
- CIA 120.2K
- SGMO 15.7M
- Earning Date
- CIA 11-07-2024
- SGMO 11-12-2024
- Dividend Yield
- CIA N/A
- SGMO N/A
- EPS Growth
- CIA N/A
- SGMO N/A
- EPS
- CIA 0.43
- SGMO N/A
- Revenue
- CIA $248,376,000.00
- SGMO $52,291,000.00
- Revenue This Year
- CIA N/A
- SGMO N/A
- Revenue Next Year
- CIA $4.17
- SGMO $71.79
- P/E Ratio
- CIA $10.57
- SGMO N/A
- Revenue Growth
- CIA 3.02
- SGMO N/A
- 52 Week Low
- CIA $1.78
- SGMO $0.30
- 52 Week High
- CIA $5.95
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- CIA 49.60
- SGMO 54.17
- Support Level
- CIA $4.28
- SGMO $1.72
- Resistance Level
- CIA $5.29
- SGMO $3.18
- Average True Range (ATR)
- CIA 0.28
- SGMO 0.39
- MACD
- CIA -0.09
- SGMO -0.03
- Stochastic Oscillator
- CIA 29.50
- SGMO 24.67
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.